Southern California Permanente Medical Group, USA
Posters & Accepted Abstracts: J. med phys & appl sci 2018
Radioactive iodine ablations (RAI) with Iodine-131 (131I ) have been performed for decades in several countries. This presentation will provide a review of regulatory requirements for management of these patients and compare requirements around the world. Following the presentation, the attendee will have met the following objectives: review thyroid cancer types and treatment options; review regulatory requirements related to 131I treatment: determination, instructions, written directives, release. I will share my experience as a member of a team that provided training in Lusaka, Zambia in Jul’ 2017.